The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, open-label phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophagogastric junction and high immune responsiveness: The IKF633/DANTE trial, a trial of AIO in collaboration with SAKK.
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - Frankfurter Institut für Klinische Krebsforschung IKF GmbH; Immutep
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; Eli Lilly Germany; Merck Sharp & Dohme
Speakers' Bureau - AIO gGmbH; Bristol-Myers Squibb; Lilly; MCI Group
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Eurozyto; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Immutep; Ipsen; Lilly; MSD Sharp & Dohme; Roche; Sanofi; Vifor Pharma
 
Sylvie Lorenzen
No Relationships to Disclose
 
Vera Heuer
No Relationships to Disclose
 
Stefan Angermeier
No Relationships to Disclose
 
Thomas Jens Ettrich
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Ipsen; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER; Takeda
Research Funding - Baxalta/Shire; Lilly (Inst)
Travel, Accommodations, Expenses - Ipsen; Lilly
 
Nils Homann
Consulting or Advisory Role - Amgen; BMS GmbH & Co. KG; Lilly; MSD Oncology; SERVIER
 
Georg Martin Haag
Honoraria - AstraZeneca; Bristol-Myers Squibb; Lilly; MCI conventions; MSD Oncology; SERVIER; Swiss Cancer League
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb (Inst); Daiichi Sankyo Europe GmbH; Lilly; MSD Oncology (Inst); Novartis; Pierre Fabre; SERVIER
Research Funding - DKFZ Heidelberg (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (Inst); Lilly; MSD Oncology; SERVIER
 
Annika Kurreck
Honoraria - Amgen; SERVIER; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; Medac; SERVIER
 
Alexander Stein
Consulting or Advisory Role - Amgen (Inst); AstraZeneca; Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Merck KGaA; MSD (Inst); Novartis (Inst); Pierre Fabre (Inst); Pierre Fabre (Inst); Roche; SERVIER (Inst); Taiho Oncology (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); Daiichi Sankyo Europe GmbH (Inst); Merck KGaA; Seagen (Inst); Servier
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pierre Fabre (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH
 
Volker Heinemann
Stock and Other Ownership Interests - BioNTech SE
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Celgene; GlaxoSmithKline; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen; SERVIER; Sirtex Medical
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Halozyme; Janssen; Merck; MSD; Nordic Bioscience; Novartis; Oncosil; Pierre Fabre; Roche; Servier/Pfizer; Sirtex Medical; TERUMO
Research Funding - Amgen (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Merck; MSD; Nordic Bioscience
 
Ulrich Ronellenfitsch
Consulting or Advisory Role - Fresenius Kabi
Research Funding - Intuitive Surgical (Inst)
Travel, Accommodations, Expenses - Fresenius Kabi
 
Thomas Zander
Consulting or Advisory Role - AstraZeneca; BMS; MSD Oncology; Novartis; Pfizer; Roche
 
Stefan Kubicka
No Relationships to Disclose
 
Alexander Rheinhard Siebenhuener
No Relationships to Disclose
 
Christina Kopp
Stock and Other Ownership Interests - Fresenius; Johnson & Johnson/Janssen
 
Claudia Pauligk
No Relationships to Disclose
 
Thorsten Goetze
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Foundation Medicine; Incyte; Lilly; MSD Oncology; Novartis; Roche; SERVIER
Speakers' Bureau - Lilly; MSD Oncology
Research Funding - AstraZeneca (Inst); Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe (Inst); Gemeinsamer Bundesausschuss; Incyte (Inst); Lilly (Inst)